Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: Experience from a tertiary referral centre

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 6, 2014, Pages 625-630

  Paterson, Ross W ^a   Zandi, Michael S ^b   Armstrong, Richard ^c   Vincent, Angela ^c   Schott, Jonathan M ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AXONIN 1; CASPR2 ANTIBODY; LEUCINE RICH GLIOMA INACTIVATED PROTEIN 1 ANTIBODY; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL COMPLEX ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PARANEOPLASTIC NEUROPATHY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY CARE CENTER; THYMOMA; TREATMENT RESPONSE;

EPILEPSY; LIMBIC SYSTEM; NEUROIMMUNOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; AUTOANTIBODIES; AUTOIMMUNITY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; ISAACS SYNDROME; LIMBIC ENCEPHALITIS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; POTASSIUM CHANNELS, VOLTAGE-GATED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SYRINGOMYELIA;

EID: 84899988940     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-305218     Document Type: Article

References (18)

1. Hart IK, Waters C, Vincent A, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol 1997;41:238-46. (Pubitemid 27082105)
2. Liguori R, Vincent A, Clover L, et al. Morvan 's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001;124:2417-26. (Pubitemid 33134931)
3. Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001;50:73-8.
4. Schott JM, Harkness K, Barnes J, et al. Amnesia, cerebral atrophy, and autoimmunity. Lancet 2003;361:1266. (Pubitemid 36428581)
5. Vincent A, Buckley C, Schott JM, et al . Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701-12. (Pubitemid 38295483)
6. Malter MP, Helmstaedter C, Urbach H, et al. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010;67:470-8.
7. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9:776-85.
8. Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011;69:892-900.
9. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734-48.
10. Zuliani L, Graus F, Giometto B, et al. Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry 2012;83:638-45.
11. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-40. (Pubitemid 39005770)
12. Pozo-Rosich P, Clover L, Saiz A, et al. Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol 2003;54:530-3. (Pubitemid 37176552)
13. Tan KM, Lennon VA, Klein CJ, et al. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008;70:1883-90. (Pubitemid 351684641)
14. Haberlandt E, Bast T, Ebner A, et al. Limbic encephalitis in children and adolescents. Arch Disease Childhood 2011;96:186-91.
15. Hacohen Y, Wright S, Waters P, et al. Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J. Neurol Neurosurg Psychiatry 2012;10:1136.
16. Vallet AE, Verschueren A, Petiot P, et al. Neurological features in adult Triple-A (Allgrove) syndrome. J Neurol 2012;259:39-46.
17. Fujita K, Yuasa T, Watanabe O, et al. Voltage-gated potassium channel complex antibodies in Creutzfeldt-Jakob disease. J Neurology 2012;259:2249-50.
18. Klein CJ, Lennon VA, Aston PA, et al. Insights From LGI1 and CASPR2 Potassium Channel Complex Autoantibody Subtyping. JAMA Neurol 2013;70:229-34.